Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
The January J.P. Morgan Healthcare Conference is known to bring a wave of biopharmaceutical deal-making, often with a major deal announcement timed for maximum attention. But this year continued a trend that started back with the 2020 meeting – research alliances and licensing deals dominate rather than large merger and acquisition activity. As of 13 January, the final day of the meeting, the year’s largest deal was a collaboration between Sanofiand Exscientia Ltd
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
